| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.47 | 0.006 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.22 | 0.007 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |